Lipoprotein secretion and triglyceride stores in the heart.
about
Multiple functions of microsomal triglyceride transfer proteinThe Use of SGLT-2 Inhibitors in Type 2 Diabetes and Heart FailureCardiac expression of microsomal triglyceride transfer protein is increased in obesity and serves to attenuate cardiac triglyceride accumulation.Apolipoprotein B-containing lipoproteins in retinal aging and age-related macular degeneration.ApoO, a novel apolipoprotein, is an original glycoprotein up-regulated by diabetes in human heart.Mouse models for disorders of mitochondrial fatty acid beta-oxidation.Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins.Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy.Cardiomyocyte Regulation of Systemic Lipid Metabolism by the Apolipoprotein B-Containing Lipoproteins in Drosophila.MTP inhibition as a treatment for dyslipidaemias: time to deliver or empty promises?Allele-specific regulation of MTTP expression influences the risk of ischemic heart disease.Very-low-density lipoprotein: complex particles in cardiac energy metabolism.Insights from human congenital disorders of intestinal lipid metabolism.Lack of MTTP Activity in Pluripotent Stem Cell-Derived Hepatocytes and Cardiomyocytes Abolishes apoB Secretion and Increases Cell Stress.Targeting microsomal triglyceride transfer protein and lipoprotein assembly to treat homozygous familial hypercholesterolemia.Microsomal triglyceride transfer protein expression in adipocytes: a new component in fat metabolism.Retina expresses microsomal triglyceride transfer protein: implications for age-related maculopathy.Human placenta secretes apolipoprotein B-100-containing lipoproteins.Apolipoprotein B is synthesized in selected human non-hepatic cell lines but not processed into mature lipoprotein.Reversal of intramyocellular lipid accumulation by lipophagy and a p62-mediated pathway.A mouse model reveals an important role for catecholamine-induced lipotoxicity in the pathogenesis of stress-induced cardiomyopathy.Green tea polyphenols improve cardiac muscle mRNA and protein levels of signal pathways related to insulin and lipid metabolism and inflammation in insulin-resistant rats.Overexpression of apolipoprotein B in the heart impedes cardiac triglyceride accumulation and development of cardiac dysfunction in diabetic mice.Apolipoprotein B production reduces lipotoxic cardiomyopathy: studies in heart-specific lipoprotein lipase transgenic mouse.Demonstration of reverse fatty acid transport from rat cardiomyocytes.Skeletal muscle apolipoprotein B expression reduces muscular triglyceride accumulation.Perfused hearts from Type 2 diabetic (db/db) mice show metabolic responsiveness to insulin.Manifestations and mechanisms of myocardial lipotoxicity in obesity.Expression and secretion of human apolipoprotein A-I in the heart.
P2860
Q21245057-628D96FF-26A8-49F9-98CC-FCB5C989A9BFQ28082343-29B204F0-D6D3-441E-AAE5-2522ADDEAE18Q33434386-7C3173F4-8028-4C1F-ACE1-D69A1121512EQ33634096-F378610B-BDB9-4266-80B0-28AD7FE3BEABQ34563979-D205E2B7-A372-4942-A23F-0216D39A3B12Q34578754-769C9B33-9197-4D55-88A7-7905250A88A4Q35056603-8D226997-0E0D-4633-A35B-F3A0A7983DD5Q35749021-D661F70A-AC43-4F17-9384-61A9EA51DEB9Q36251148-44F050A9-4711-4FFF-A8B8-54CDA9F63DE9Q36709542-C9A003C2-3FFA-434A-9625-DFE343FE021AQ37463241-D683FAC9-4870-400A-8BC0-41C796BE9F7EQ37902919-572472F2-77EE-403C-BD81-20160D858431Q38267212-E8857B16-6D9E-4017-9E9F-3D48B33ED6BAQ38780504-046E18AE-FF0D-4526-BAC4-79035EA2110AQ38969073-3CE99C15-FB17-400F-B005-F941F3CE0FF1Q40416058-A9DDF54B-7841-4E14-A9DE-8BCB04D82455Q40470219-0D589C53-C86C-460E-AC49-8190ECF91CE7Q40500037-9C3ACCB4-D742-4125-AB24-9BAA35A007B5Q40736669-E049C30F-180A-4460-B96E-5DDF85294D2AQ41465421-3D41C839-8A19-4E28-988B-3B7A69D33E39Q42514867-8889137C-D5D8-4F1D-B4BD-8F11B54235B2Q43181004-DD49E937-9897-4E8B-ADDA-FCCDAD932454Q43996678-A6D214DD-BD05-4E10-8095-59332EFE3913Q44666420-E0594C71-EFE1-4510-AF88-9C50E7844E50Q45041076-8B826DBA-2DA9-4D4B-8E6C-FEAE9663EC0CQ45597225-AB26A43B-1C1B-4F79-A72F-6A4E1EC495ACQ46835029-F190E93E-9018-42D9-8A61-B6B3218C9C74Q48249334-83099D0F-8BD4-4071-AB57-EC04BBB5EA3DQ54732698-C9EAD3B8-F0FC-4993-9686-1752D0F8C16E
P2860
Lipoprotein secretion and triglyceride stores in the heart.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Lipoprotein secretion and triglyceride stores in the heart.
@en
Lipoprotein secretion and triglyceride stores in the heart.
@nl
type
label
Lipoprotein secretion and triglyceride stores in the heart.
@en
Lipoprotein secretion and triglyceride stores in the heart.
@nl
prefLabel
Lipoprotein secretion and triglyceride stores in the heart.
@en
Lipoprotein secretion and triglyceride stores in the heart.
@nl
P2093
P2860
P356
P1476
Lipoprotein secretion and triglyceride stores in the heart.
@en
P2093
Bjorkegren J
Hellerstein MK
Withycombe SK
P2860
P304
38511-38517
P356
10.1074/JBC.M106839200
P407
P577
2001-07-31T00:00:00Z